No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
Bill of Health
AUGUST 29, 2022
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. On October 8, 2020, amid press coverage of an emerging inventorship dispute with the U.S. Licensing structures like this go back at least to World War II, when the U.S.
Let's personalize your content